Lower-Risk Myelodysplastic Syndromes (LR-MDS): Highlights from EHA 2024 - Episode 2
Dr Oliva on Addressing Challenges in Treating Lower-Risk MDS
Key opinion leaders address various challenges linked to lower-risk myelodysplastic syndromes, with a focus on cytopenias.
- Dr Garcia-Manero to Dr Oliva: What present challenges exist for treating patients with lower-risk MDS? Do not take to transplant. Challenge for other cytopenias—no drug for this. Remission of low-risk disease.